Intelligent Medicine

Intelligent Medicine was established to merge with one or more businesses, exchange capital shares, acquire assets, purchase shares, undergo restructuring, or engage in similar business combinations. Although the company's efforts to identify potential business combination opportunities will not be limited to a specific industry, it intends to focus on life science companies that leverage artificial intelligence, machine learning, and big data to drive drug discovery.